Brentuximab Vedotin
About Brentuximab Vedotin
Brentuximab Vedotin is a targeted prescription medicine used to treat certain types of blood cancers, specifically Hodgkin lymphoma and systemic anaplastic large cell lymphoma. It is prescribed for patients whose cancer has progressed or returned after other treatments. This medicine is given as an intravenous infusion directly into a vein.
Because this medicine is given as an infusion by a healthcare provider, it is usually taken once every three weeks. Keeping your scheduled appointments is essential to ensure the medicine works consistently in your body. While food intake does not affect this intravenous treatment, staying well-hydrated and eating a balanced diet can help your body tolerate the therapy.
Many people experience mild side effects, such as nerve tingling, fatigue, or nausea. However, you must contact your doctor immediately if you face specific serious side effects like severe numbness, breathing difficulties, or signs of a serious infection.
Do not take this if you are currently receiving a chemotherapy medicine called bleomycin, as this combination can cause severe lung damage. Talk to your doctor before starting it if you have a history of liver damage, kidney disease, or nerve problems like numbness or tingling in your hands or feet.
Certain medicines can affect how your liver processes it, which may increase your risk of severe side effects. It is also important to avoid alcohol and smoking during treatment, as they can put extra stress on your liver and lungs. If you are pregnant, planning to become pregnant, breastfeeding, or are an older adult, consult your doctor to discuss the risks and benefits of this treatment.
Uses of Brentuximab Vedotin
Medicinal Benefits
When taken consistently as directed, this medicine may provide the following physiological benefits:
- Targets lymphoma cells: This medicine works by targeting and destroying lymphoma cells, which may help control the growth and spread of cancer while limiting damage to healthy cells.
- Helps manage lymphoma: This treatment may help reduce tumour size, achieve remission, or delay disease progression in some patients. By controlling the disease, it may also help relieve symptoms such as night sweats, unexplained fever, and persistent itching.
Directions for Use
- Follow your doctor's instructions on the dosage and timing of this medication to ensure safe and effective use.
- Brentuximab Vedotin will be administered by the doctor or healthcare professional.
- Do not self-administer.
Storage
Side Effects of Brentuximab Vedotin
Common Side Effects (Usually mild):
- Numbness, tingling, or burning sensation in the hands or feet
- Feeling tired or weak
- Nausea or diarrhea
- Fever or mild respiratory infections
Serious Side Effects (Consult your doctor right away):
- Signs of a severe allergic reaction, such as swelling of the face, lips, or throat, or trouble breathing
- Severe, persistent numbness, weakness, or pain in your hands or feet
- Signs of liver damage, including yellowing of the skin or eyes, dark urine, or severe upper stomach pain
- High fever, chills, cough, or other sudden signs of infection
- Severe, peeling skin rash
- Nausea, vomiting, muscle cramps, weakness, irregular heartbeat, confusion, or reduced urine output (sign of tumour lysis syndrome)
- Confusion, memory problems, changes in vision, difficulty speaking, weakness or numbness, loss of coordination, or trouble walking (sign of PML- Progressive Multifocal Leukoencephalopathy)
Medicines Containing this Salt
View AllDrug Warnings
- Monitor for infusion reactions: Watch closely for itching, chills, fever, or breathing issues during and immediately after your infusion, and tell your nurse right away if they occur.
- Check the solution: Before administration, the healthcare provider will inspect the liquid. It should be clear to slightly cloudy or milky in appearance and colourless. Do not allow the infusion if there are floating particles or discolouration.
- Prevent pregnancy: Both men and women should use highly effective birth control during treatment and for several months after the final dose to prevent birth defects.
- Report signs of infection: Check your temperature regularly and report even a mild fever to your doctor immediately, as your white blood cell count may drop during therapy.
- Regular blood tests: Your doctor will perform blood tests, including complete blood count (CBC) and liver function tests, before and during treatment to monitor for side effects such as low blood cell counts or liver problems.
- Treatment schedule: Do not stop or change your infusion schedule on your own. Always consult your oncologist before missing, delaying, or stopping treatment.
- Dose adjustments: Your doctor may delay treatment, reduce the dose, or make other changes if you develop side effects such as nerve damage (peripheral neuropathy) or low blood cell counts.
Drug Interactions
- Bleomycin: Do not take this if you are receiving bleomycin, as combining these medicines significantly increases the risk of life-threatening lung damage.
- Strong CYP3A4 inhibitors (such as ketoconazole): These medicines can block liver enzymes that break down drugs in your body, increasing the level of this medicine and the risk of side effects.
- Strong CYP3A4 inducers (such as rifampin): These medicines can increase liver enzyme activity, lowering the level of this medicine and possibly reducing its effectiveness.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
consult your doctorAvoid alcohol consumption of alcohol if you are receiving Brentuximab Vedotin, as it can exacerbate potential side effects of the medication, especially liver problems, and may interfere with the effectiveness of treatment. Always consult your doctor before consuming alcohol while taking this medication.
Pregnancy
unsafeBrentuximab Vedotin can harm your foetus. If you are a woman receiving Brentuximab Vedotin, avoid pregnancy. If you become pregnant while on treatment, report immediately to the doctor.
Breast Feeding
unsafeAvoid breastfeeding while on treatment with Brentuximab Vedotin as it may harm your baby.
Driving
cautionAvoid driving or operating machinery if you feel uncomfortable after receiving Brentuximab Vedotin.
Liver
cautionThere have also been severe hepatotoxic cases with potentially deadly results. The risk may also be raised by comorbidities, concurrent drugs, and pre-existing liver disease. Before starting Brentuximab Vedotin, liver function should be assessed, and patients should have regular liver function checks.
Kidney
cautionBrentuximab Vedotin should not be used in people who have significant renal impairment (creatinine clearance < 30 mL/min). Patients with severe renal impairment may use it, provided that their dosage is adjusted and they are closely monitored.
Children
safe if prescribedBrentuximab Vedotin in combination with other chemotherapeutic agents like doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide can be used safely in children 2 years of age and older with previously untreated high-risk classical Hodgkin lymphoma (cHL). Your doctor may recommend the correct combination and dosage based on the child's condition.
Habit Forming
Diet & Lifestyle Advise
- Prioritise nerve safety: Since nerve tingling or numbness is a common side effect, protect your hands and feet by wearing comfortable, supportive shoes and avoiding exposure to extreme heat or cold.
- Eat small, frequent meals: If you experience nausea or a loss of appetite, eating smaller portions throughout the day can help maintain your strength and energy.
- Stay hydrated: Drink plenty of fluids, such as water or clear broths, to support your kidneys and liver as they process the medicine.
- Avoid raw or undercooked foods: Your immune system may be weakened during treatment. Stick to well-cooked meals and wash all fruits and vegetables thoroughly to prevent infections.
- Get gentle exercise: Short, light walks can help combat treatment-related fatigue, but always listen to your body and rest when needed.
Patients Concern
Disease/Condition Glossary
Hodgkin's lymphoma: Hodgkin’s disease or Hodgkin's lymphoma is a blood cancer of a specific type of cells called WBCs, specifically lymphocytes. Lymphocytes are key in controlling infections and supporting the body’s immune function. However, in a cancerous state, there is an abnormal multiplication of these blood cells, causing many problems such as fatigue, fever, loss of appetite, itching, night sweats and lymph node swelling.
FAQs
Brentuximab Vedotin belongs to the group of medications called Monoclonal antibodies used to treat Hodgkin’s disease or Hodgkin's lymphoma.
Brentuximab Vedotin contains Brentuximab vedotin. It works by targeting a protein called CD30, which is found on the surface of cancerous cells. It is an antibody-drug conjugate that delivers a toxic substance directly to these cells, leading to their destruction. This process helps reduce tumour growth and improve symptoms in patients with Hodgkin lymphoma.
Contact your doctor immediately if you experience fever, chills, rash, hives, itching, or difficulty breathing during or after 24 hours of receiving Brentuximab Vedotin. Your doctor may prescribe medications before your infusion to help prevent allergic reactions if you've had one previously.
Brentuximab Vedotin may cause common side effects, such as dizziness, constipation, decreased appetite, mouth sores, anxiety, bone pain, muscle pain, joint pain, leg pain, back pain, arm pain, and hair loss. However, please consult your doctor if any of these symptoms persist or worsen.
Please inform your doctor before taking any other medicines while treatment with Brentuximab Vedotin. Your doctor will decide regarding medicines that should not be taken along with Brentuximab Vedotin.
It is given as an intravenous (IV) infusion into a vein by a healthcare provider, usually over 30 minutes. Talk to your doctor if you have questions about your schedule.
No, it can cause harm to an unborn baby. You must use effective birth control during treatment and for several months after. Talk to your doctor if you are pregnant or planning to become pregnant.
It is typically given once every three weeks, but your exact schedule depends on your specific condition and how well you tolerate the medicine. Talk to your doctor about your treatment plan.
It is best to avoid alcohol during treatment because it can put extra strain on your liver, which is already processing the medication. Talk to your doctor or pharmacist for specific advice.
This medicine can cause nerve damage, leading to numbness, tingling, or weakness in your hands and feet. Your doctor may need to adjust your dose if this happens. Talk to your doctor if you notice these symptoms.
You should avoid live vaccines during treatment, as your immune system may be weakened. Always talk to your doctor or pharmacist before getting any vaccination.
This medicine may affect fertility. If you plan to have children in the future, discuss fertility preservation options, such as sperm banking or egg preservation, with your doctor before starting treatment.
